Cargando…
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR
The PI3K/PTEN/Akt/mTOR/p70S6K pathway is one of the most frequently deregulated signaling pathways in solid tumors and has a functional role in drug resistance. However, targeting this pathway leads to compensatory activation of several mediators of cell survival. Expression of the reactive oxygen s...
Autores principales: | Deng, Xiaobing, Hu, Jing, Ewton, Daina Z., Friedman, Eileen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146409/ https://www.ncbi.nlm.nih.gov/pubmed/24590896 http://dx.doi.org/10.1093/carcin/bgu058 |
Ejemplares similares
-
Mirk/dyrk1B Kinase in Ovarian Cancer
por: Friedman, Eileen
Publicado: (2013) -
The normal function of the cancer kinase Mirk/dyrk1B is to reduce reactive oxygen species
por: Deng, Xiaobing, et al.
Publicado: (2014) -
The Kinase Mirk/dyrk1B: A Possible Therapeutic Target in Pancreatic Cancer
por: Friedman, Eileen
Publicado: (2010) -
Mirk kinase inhibition targets ovarian cancer ascites
por: Deng, Xiaobing, et al.
Publicado: (2014) -
Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells
por: Deng, Xiaobing, et al.
Publicado: (2014)